Pregled bibliografske jedinice broj: 1273762
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression // Expert Review of Molecular Diagnostics, 23 (2023), 4; 283-296 doi:10.1080/14737159.2023.2200937 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1273762 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The association of brain-derived neurotrophic factor with the diagnosis and treatment response in depression
Autori
Nikolac Perkovic, Matea ; Gredicak, Martin ; Sagud, Marina ; Nedic Erjavec, Gordana ; Uzun, Suzana ; Pivac, Nela
Izvornik
Expert Review of Molecular Diagnostics (1473-7159) 23
(2023), 4;
283-296
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
BDNF ; BDNF Val66Met ; antidepressants ; depression ; treatment response
Sažetak
Introduction: Recent evidence from the studies evaluating the association between brain-derived neurotrophic factor (BDNF) concentration/levels, BDNF Val66Met (rs6265) polymorphism, and major depressive disorders, referred as depression, and the association between BDNF levels and/or BDNF Val66Met with the treatment response in depression is presented. Areas covered: This mini review focuses on the changes in the peripheral BDNF levels in blood (serum, plasma, platelets) in patients with depression before or after treatment with antidepressant drugs or different therapeutic strategies. In addition, this review describes the recent data on the possible association between different antidepressants/therapeutic strategies and the particular BDNF Val66Met genotypes, evaluating the risk alleles associated with the response in patients with depression. Expert opinion: BDNF has an important role in the pathophysiology and treatment response in depression. Most data reveal that peripheral BDNF levels are lower before than after antidepressant treatment and might be used as potential biomarkers of therapeutic response. Novel therapeutic strategies should target restoring/increasing BDNF levels
Izvorni jezik
Engleski
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Zagreb,
Klinički bolnički centar Zagreb
Profili:
Suzana Uzun
(autor)
Gordana Nedić Erjavec
(autor)
Marina Šagud
(autor)
Nela Pivac
(autor)
Matea Nikolac Perković
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE